TY - JOUR
T1 - Rural risk environments, opioid-related overdose, and infectious diseases
T2 - A multidimensional, spatial perspective
AU - Kolak, Marynia A.
AU - Chen, Yen Tyng
AU - Joyce, Sam
AU - Ellis, Kaitlin
AU - Defever, Kali
AU - McLuckie, Colleen
AU - Friedman, Sam
AU - Pho, Mai T.
N1 - Funding Information:
This work was supported by the National Institutes of Health [ 5UG3DA044829-02 ] and the Agency for Healthcare Research and Quality [ 4R00HS022433-03 ].
Publisher Copyright:
© 2020
PY - 2020/11
Y1 - 2020/11
N2 - Background: Much remains unknown in rural risk environments, despite a growing crisis in these areas. We adapt a risk environment framework to characterize rural southern Illinois and describe the relations of risk environments, opioid-related overdose, HIV, Hepatitis C, and sexually transmitted infection rates between 2015 and 2017. Methods: Over two dozen risk environment variables are summarized across zip-code (n = 128) or county levels (n = 16) based on availability and theoretical relevance. We calculate data attribute associations and characterize spatial and temporal dimensions of longitudinal health outcomes and the rural risk environment. We then use a “regional typology analysis” to generate data-driven risk regions and compare health outcomes. Results: Pervasive risk hotspots were identified in more populated locales with higher rates of overdose and HCV incidence, whereas emerging risk areas were isolated to more rural locales that had experienced an increase in analgesic opiate overdoses and generally lacked harm-reduction resources. At-risk areas were characterized with underlying socioeconomic vulnerability but in differing ways, reflecting a nuanced and shifting structural risk landscape. Conclusions: Rural risk environment vulnerabilities and associated opioid-related health outcomes are multifaceted and spatially heterogeneous. More research is needed to better understand how refining geographies to more precisely define risk can support intervention efforts and further enrich investigations of the opioid epidemic.
AB - Background: Much remains unknown in rural risk environments, despite a growing crisis in these areas. We adapt a risk environment framework to characterize rural southern Illinois and describe the relations of risk environments, opioid-related overdose, HIV, Hepatitis C, and sexually transmitted infection rates between 2015 and 2017. Methods: Over two dozen risk environment variables are summarized across zip-code (n = 128) or county levels (n = 16) based on availability and theoretical relevance. We calculate data attribute associations and characterize spatial and temporal dimensions of longitudinal health outcomes and the rural risk environment. We then use a “regional typology analysis” to generate data-driven risk regions and compare health outcomes. Results: Pervasive risk hotspots were identified in more populated locales with higher rates of overdose and HCV incidence, whereas emerging risk areas were isolated to more rural locales that had experienced an increase in analgesic opiate overdoses and generally lacked harm-reduction resources. At-risk areas were characterized with underlying socioeconomic vulnerability but in differing ways, reflecting a nuanced and shifting structural risk landscape. Conclusions: Rural risk environment vulnerabilities and associated opioid-related health outcomes are multifaceted and spatially heterogeneous. More research is needed to better understand how refining geographies to more precisely define risk can support intervention efforts and further enrich investigations of the opioid epidemic.
KW - Opioid overdose
KW - Regionalization
KW - Rural risk environment
KW - Spatial analysis
UR - http://www.scopus.com/inward/record.url?scp=85086040696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086040696&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2020.102727
DO - 10.1016/j.drugpo.2020.102727
M3 - Article
C2 - 32513621
AN - SCOPUS:85086040696
SN - 0955-3959
VL - 85
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 102727
ER -